Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −375,399−100.0% | Sold out | Holders |
| Q2 2022 | 375,399 | $19.4M | 0.1% | +12,649+3.5% | Added | Holders |
| Q1 2022 | 362,750 | $26.4M | 0.1% | −584,084−61.7% | Reduced | Holders |
| Q4 2021 | 946,834 | $112.0M | 0.3% | −103,965−9.9% | Reduced | Holders |
| Q3 2021 | 1,050,799 | $141.0M | 0.3% | +159,899+17.9% | Added | Holders |
| Q2 2021 | 890,900 | $144.2M | 0.3% | +211,759+31.2% | Added | Holders |
| Q1 2021 | 679,141 | $54.5M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.